Dr. Michael Anthony Galbreath, MD

Dr. Galbreath practices at PIH Health Physicians in Whittier, California.

Dr. Galbreath's NPI, 1255840799, was assigned on September 27, 2017. Dr. Galbreath holds California license A166514.

Dr. Galbreath's primary practice is PIH Health Physicians, at 12522 E Lambert Rd, Whittier, CA 90606 in Los Angeles County. The practice phone is (562) 789-5420.

Dr. Galbreath's primary practice is PIH Health Physicians in Whittier, California. Dr. Galbreath is also affiliated with PIH Health Whittier Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Galbreath to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galbreath practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Galbreath's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Galbreath is licensed in California.

CMS data shows 418 Medicare services from Dr. Galbreath across 6 procedure codes in 2024, for 188 Medicare patients. Medicare paid $35,055 for them. Every service was in an office.

CMS counts 188 Medicare patients who saw Dr. Galbreath in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Galbreath's median patient age at 69, with 44% women.

In 2024, Dr. Galbreath wrote 10,294 Medicare Part D claims for 887 patients. 89% of them were for generic drugs. CMS names the drug for 9,595 of them, across 114 drugs with 11 or more claims each, at $705,415 in total drug cost. In 2023, CMS named 8,865 claims across 119 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Galbreath for performance year 2024, reported as part of a group. Dr. Galbreath accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Galbreath as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Galbreath, published from 2013 to 2016. The most frequent topics are Molecular Structure and Structure-Activity Relationship. Dr. Galbreath has published most often in Bioorg Med Chem Lett. Dr. Galbreath's most frequent co-author is William A. Jackson, MD.

CMS Open Payments shows 3 general payments to Dr. Galbreath from 1 drug or device company from 2021 to 2022. Food and beverage make up the largest share, 100% of the total. Organon LLC paid the most, $93.